Télécharger le texte intégral - ISPED-Enseignement à distance

182
149. Brinkman K. Editorial response: hyperlactatemia and hepatic steatosis as features of
mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors. Clin Infect Dis
2000;31(1):167-169.
150. Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC. Lactic acidemia in human
immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. Pediatr
Infect Dis J 2003;22(9):782-789.
151. Giaquinto C, Torresan S, Rampon O, Ruga E, Fregonese F, Eseme Esoka F, et al. Lactic acid
in infants perinatally exposed to antiretrovirals. XIV international AIDS Conference. 7-12 July
2002; Barcelona, Spain (abstract WePeB5940).
152. Rouet F, Coulibaly N, Ekouevi D, Chaix M, Burgard M, Bequet L, et al. Real-time PCR
technology developed for the detection of HIV-1 RNA and HIV-2 DNA permits an
inexpensive and early diagnosis of HIV infection in African neonates from Côte d'Ivoire. The
13th International Conference on AIDS & STIs in Africa. September 2003; Nairobi, Kenya.
(abstract 879186).
153. Rouet F, Coulibaly N, Ekouevi D, Chaix M, Burgard M, Bequet L, et al. Real-time PCR
technology developed for the detection of HIV-1 RNA and HIV-2 DNA permits an
inexpensive and early diagnosis of HIV infection in African neonates from Côte d'Ivoire. The
2nd IAS Conference on HIV Pathogenesis and Treatment.13-16 July 2003; Paris, France;
(abstract 277). Antiviral Therapy 2003; 8 (Suppl1):S252.
154. Noguera A, Perez-Duenas B, Tello L, Artuch R, Garcia-Fructuoso M, Munoz M. Lactic
acidosis in newborns exposed to HIV and antiretrovirals.. XIV International AIDS
Conference. 7-12 July 2002; Barcelona, Spain; (abstract WePeB5951)
155. Cote HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, et al. Changes in
mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J
Med 2002;346(11):811-20.
156. Piot P. Peter Piot-executive director of UNAIDS. Interview by Pam Das. Lancet Infect Dis
2003;3(12):809-13.
157. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV
serostatus diclosure among women in developing countries: implications for prevention of
mother-to-child transmission programmes. Bull World Health Organ 2004;82(4):299-307.
158. De Cock KM, Mbori-Ngacha D, Marum E. Aids in Africa V: Shadow on the continent: public
health and HIV/AIDS in Africa in the 21st century. Lancet 2002;360(9326):67-72.
159. Cartoux M, Meda N, Van de Perre P, Newell ML, de Vincenzi I, Dabis F. Acceptability of
voluntary HIV testing by pregnant women in developing countries: an international survey.
Ghent International Working Group on Mother-to-Child Transmission of HIV. AIDS 1998;
12(18):2489-93.
160. Cartoux M, Msellati P, Meda N, Welffens-Ekra C, Mandelbrot L, Leroy V, et al. Attitude of
pregnant women towards HIV testing in Abidjan, Cote d'Ivoire and Bobo-Dioulasso, Burkina
Faso. DITRAME Study Group (ANRS 049 Clinical Trial). Diminution de la Transmission
Mere Enfant du VIH. Agence Nationale de Recherches sur le SIDA. AIDS 1998;12(17):2337-
44.
161. Walmsley S. Opt in or opt out: What is optimal for prenatal screening for HIV infection Can
Med Assoc J 2003;168(6):707-708.